Training Program to Improve EEG Competence (EPI-Train)

July 4, 2026 updated by: Leona Möller, University Hospital Marburg

Implementation of a Training Program to Improve EEG Competence in Neurocritical Care Nursing and Non-Physician Treatment Teams for the Recognition of Epileptiform and Ictal Patterns (EPI-TRAIN: EEG Training for the Detection of Pathological Ictal Patterns in Neurocritical Care)

The goal of this clinical trial is to investigate the extent to which a practice-oriented training program for intensive care nursing staff and non-physician treatment teams can contribute to the earlier detection of epileptic seizures, with particular emphasis on SE.

Further objectives include enhancing competence in EEG interpretation and minimizing existing communication and procedural barriers within the interdisciplinary treatment team.

Participants will participate in a half-day training session, which will include:

  • attending a specialist lecture,
  • completing two knowledge assessments and one evaluation questionnaire,
  • completing an additional brief evaluation questionnaire after one month, and
  • completing a further brief evaluation questionnaire after three months to assess the sustainability of the learning outcomes.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Germany
    • Hesse
      • Marburg, Hesse, Germany, 35043
        • University Hospital Marburg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • neurocritical care nursing staff and non-physician treatment teams at the Neurocritical Care Units of Marburg University Hospital

Exclusion Criteria:

  • under 18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training Group
Other: Training Program
1x Training Program for the neurocritical care nursing staff and non-physician treatment teams at the Neurocritical Care Units

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of correct responses on the study-specific 16-item EEG Knowledge Questionnaire
Time Frame: Baseline (before the training session) and immediately after completion of the training session (Day 0).
Number of correctly answered items (range 0-16) on a study-specific 16-item multiple-choice questionnaire assessing EEG knowledge and seizure recognition.
Baseline (before the training session) and immediately after completion of the training session (Day 0).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Responses to items of a study-specific EEG training evaluation questionnaire (6-point Likert scale)
Time Frame: Immediately after completion of the training session (Day 0), approximately 1 month (30 ± 7 days), and approximately 3 months (90 ± 14 days) after completion of the training session.
Responses to individual questionnaire items evaluating participants' perceptions of the training program and EEG use in clinical practice. Individual item scores (1 = strongly agree to 6 = strongly disagree) will be reported separately.
Immediately after completion of the training session (Day 0), approximately 1 month (30 ± 7 days), and approximately 3 months (90 ± 14 days) after completion of the training session.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital Marburg

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 4, 2025

Primary Completion (Actual)

January 27, 2026

Study Completion (Actual)

May 31, 2026

Study Registration Dates

First Submitted

June 8, 2026

First Submitted That Met QC Criteria

July 4, 2026

First Posted (Actual)

July 8, 2026

Study Record Updates

Last Update Posted (Actual)

July 8, 2026

Last Update Submitted That Met QC Criteria

July 4, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 25-170 BO

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

  • Two knowledge assessments and one evaluation questionnaire directly after the training program
  • Additional brief evaluation questionnaire after one month and after three months

IPD Sharing Time Frame

From 01.06.26 till 01-06-2036

IPD Sharing Access Criteria

Consent from the Principal Investigator (PI) Leona Möller

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epilepsy

Clinical Trials on Training Program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe